Hepatitis C prevalence reaches 2% of US population:
This article was originally published in Clinica
Hepatitis C has become the most chronic blood borne infection in the US with prevalence reaching 1.8% of the population, according to the country's third National Health and Nutrition Examination Survey. The survey, reported in the August 19 issue of the New England Journal of Medicine, indicates that 3.9 million people have hepatitis C infection with almost 70% of this figure chronically infected. The strongest factors associated with infection are illegal drug use and high-risk sexual behaviour. Between 8,000 and 10,000 deaths occur annually from liver complications associated with hepatitis C, says the survey.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.